Rucha Patil: Insights from The National Haemophilia Conclave 2026
Rucha Patil, Scientist at Department of Haemostasis and Thrombosis, ICMR- National Institute of Immunohaematology, shared on LinkedIn:
”National Haemophilia Conclave 2026
Policy, Protocols, Procedures and the Roadmap Ahead
Delhi | 16–17 May 2026
Delighted to be invited as a speaker at the conclave and present on the topic:
‘Lab Monitoring of Novel Therapies in Haemophilia: Is Thrombin Generation Assay Emerging as a Gold Standard?’ – a very engaging and thought-provoking topic.
It was also an honour to chair a session alongside one of my mentors, Dr. Kanjaksha Ghosh, as co-chair, while another of my mentors delivered the lecture — truly a special moment for me.
Had the opportunity to moderate a very important panel discussion on ‘Haemophilia in Women and Girls: Expanding the Diagnostic Criteria’ with distinguished panelists Dr. KK Radhika, Dr. Smita Kaushik, Dr. Alka Yadav, Dr. Sunita Aggarwal and Dr. Priyanka Agarwal.
A truly enriching and impactful meeting, wonderfully organised by Dr. Naresh Gupta sir and his team.”
Stay updated with Hemostasis Today.
-
May 22, 2026, 10:11Narat Srivali: New Systematic Review and Meta-Analysis on Glucocorticoid Therapy and The Risk of VTE
-
May 22, 2026, 10:02Greta Mulders: Nursing Leadership in Haemophilia Gene Therapy
-
May 22, 2026, 08:45Dirk Sibbing: Ethnicity and Antiplatelet Therapy Outcomes in CCS
-
May 22, 2026, 08:35Jason Brandon: On Lyophilized Hemostatic Supplementation at Simmons Research Day 2026
-
May 22, 2026, 08:28Inconsistent D-Dimer Assay Reporting in VTE Studies – JTH
-
May 22, 2026, 08:21Vincent Jongkind: We Invite You to Participate in a Delphi Study for a Core Outcome Set in Acute Limb Ischemia
-
May 22, 2026, 07:46Jae Hyun Byun: Spatial Transcriptomics and the Emerging Complexity of Plaque Vulnerability
-
May 22, 2026, 07:45Thom Lysen: Tracking TTS Risk After COVID-19 Viral Vector-Based Vaccines
-
May 22, 2026, 07:44WFH Celebrates Landmark Progress at the 79th World Health Assembly